Johnson & Johnson (NYSE:JNJ)
One of only 22 companies to increase dividends every year for at least 50 consecutive years, Johnson & Johnson increased total sales in the first quarter 12.6% to over $20 billion. As the world’s largest medical conglomerate, they are well positioned to provide medicine and care for aging Baby Boomers.
From Jeff Auxier (Trades, Portfolio)'s second quarter 2018 shareholder letter.